These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single molecule effects of osteogenesis imperfecta mutations in tropocollagen protein domains. Gautieri A; Vesentini S; Redaelli A; Buehler MJ Protein Sci; 2009 Jan; 18(1):161-8. PubMed ID: 19177360 [TBL] [Abstract][Full Text] [Related]
3. Hierarchical structure and nanomechanics of collagen microfibrils from the atomistic scale up. Gautieri A; Vesentini S; Redaelli A; Buehler MJ Nano Lett; 2011 Feb; 11(2):757-66. PubMed ID: 21207932 [TBL] [Abstract][Full Text] [Related]
4. Tendon and motor phenotypes in the Grol MW; Haelterman NA; Lim J; Munivez EM; Archer M; Hudson DM; Tufa SF; Keene DR; Lei K; Park D; Kuzawa CD; Ambrose CG; Eyre DR; Lee BH Elife; 2021 May; 10():. PubMed ID: 34036937 [TBL] [Abstract][Full Text] [Related]
5. Mutations in COL1A1 Gene Change Dentin Nanostructure. Duan X; Liu Z; Gan Y; Xia D; Li Q; Li Y; Yang J; Gao S; Dong M Anat Rec (Hoboken); 2016 Apr; 299(4):511-9. PubMed ID: 26694865 [TBL] [Abstract][Full Text] [Related]
6. Structure-mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model. Andriotis OG; Chang SW; Vanleene M; Howarth PH; Davies DE; Shefelbine SJ; Buehler MJ; Thurner PJ J R Soc Interface; 2015 Oct; 12(111):20150701. PubMed ID: 26468064 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic Properties of Collagen in Dentinogenesis Imperfecta Associated with Osteogenesis Imperfecta. Ibrahim S; Strange AP; Aguayo S; Shinawi A; Harith N; Mohamed-Ibrahim N; Siddiqui S; Parekh S; Bozec L Int J Nanomedicine; 2019; 14():9423-9435. PubMed ID: 31819441 [TBL] [Abstract][Full Text] [Related]
8. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site. Radmer RJ; Klein TE Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897 [TBL] [Abstract][Full Text] [Related]
10. Nanomechanics of collagen fibrils under varying cross-link densities: atomistic and continuum studies. Buehler MJ J Mech Behav Biomed Mater; 2008 Jan; 1(1):59-67. PubMed ID: 19627772 [TBL] [Abstract][Full Text] [Related]
11. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite. Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936 [TBL] [Abstract][Full Text] [Related]
12. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure. Hald JD; Folkestad L; Harsløf T; Lund AM; Duno M; Jensen JB; Neghabat S; Brixen K; Langdahl B Osteoporos Int; 2016 Nov; 27(11):3331-3341. PubMed ID: 27256333 [TBL] [Abstract][Full Text] [Related]
13. OIM and related animal models of osteogenesis imperfecta. Shapiro JR; Mcbride DJ; Fedarko NS Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365 [TBL] [Abstract][Full Text] [Related]
14. [Prenatal and neonatal diagnosis of osteogenesis imperfecta in obstetrical practice]. Leśniewicz R; Galicka A; Anchim T; Skotnicki M; Wołczyński S; Urban J Ginekol Pol; 2001 Jun; 72(6):456-65. PubMed ID: 11526743 [TBL] [Abstract][Full Text] [Related]
15. The interaction between Sillence type and BMD in osteogenesis imperfecta. Kok DJ; Uiterwaal CS; Van Dongen AJ; Kramer PP; Pruijs HE; Engelbert RH; Verbout AJ; Schweitzer DH; Sakkers RJ Calcif Tissue Int; 2003 Nov; 73(5):441-5. PubMed ID: 12958692 [TBL] [Abstract][Full Text] [Related]
16. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022 [TBL] [Abstract][Full Text] [Related]
17. Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Bodian DL; Chan TF; Poon A; Schwarze U; Yang K; Byers PH; Kwok PY; Klein TE Hum Mol Genet; 2009 Feb; 18(3):463-71. PubMed ID: 18996919 [TBL] [Abstract][Full Text] [Related]
18. Glycine to tryptophan substitution in type I collagen in a patient with OI type III: a unique collagen mutation. Nuytinck L; Tükel T; Kayserili H; Apak MY; De Paepe A J Med Genet; 2000 May; 37(5):371-5. PubMed ID: 10807697 [TBL] [Abstract][Full Text] [Related]
19. Structural models of osteogenesis imperfecta-associated variants in the COL1A1 gene. Mooney SD; Klein TE Mol Cell Proteomics; 2002 Nov; 1(11):868-75. PubMed ID: 12488462 [TBL] [Abstract][Full Text] [Related]
20. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix. Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]